TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Bioconnect AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
11,314
|
9,752
|
8,413 |
Financial expenses |
90
|
95
|
71 |
Earnings before taxes |
28,012
|
2,334
|
1,359 |
Total assets |
32,507
|
4,900
|
2,883 |
Current assets |
31,808
|
4,401
|
2,334 |
Current liabilities |
13,638
|
1,533
|
1,373 |
Equity capital |
18,859
|
3,365
|
1,507 |
- share capital |
99
|
106
|
103 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
58.0%
|
68.7%
|
52.3% |
Turnover per employee | |||
Profit as a percentage of turnover |
247.6%
|
23.9%
|
16.2% |
Return on assets (ROA) |
86.4%
|
49.6%
![]() |
49.6% |
Current ratio |
233.2%
|
287.1%
|
170.0% |
Return on equity (ROE) |
148.5%
|
69.4%
|
90.2% |
Change turnover |
2,207
|
1,078
|
-1,967 |
Change turnover % |
24%
|
12%
|
-19% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.